We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Role of nitric oxide/cyclic GMP in myocardial adenosine A[sub1] receptor-inotropic response.
- Authors
Sterin-Borda, Leonor; Gomez, Ricardo M.; Borda, Enri
- Abstract
1 In this study we have determined the different signalling pathways involved in adenosine A[sub 1]receptor (A[sub 1]-receptor)-dependent inhibition of contractility in rat isolated atria. 2 N-cyclopentyladenosine (CPA) stimulation of A[sub 1]-receptor exerts: negative inotropic response, inositol phosphates accumulation, stimulation of nitric oxide synthase (NOS), increased production of nitric oxide (NO) and cyclic GMP. 3 Inhibitors of phospholipase C (PLC), protein kinase C (PKC), calcium/calmodulin, NOS and guanylate cyclase shifted the dose-response curve of CPA on contractility to the right. Those inhibitors also attenuated the A[sub 1]-receptor-dependent increase in cyclic GMP and activation of NOS. 4 These results suggest that CPA activation of A[sub 1]-receptors exerts a negative inotropic effect associated with increased production of nitric oxide and cyclic GMP. The mechanism appears to occur secondarily to stimulation of phosphoinositide turnover via PLC activation. This, in turn, triggers cascade reactions involving calcium/calmodulin and PKC, leading to activation of NOS and soluble guanylate cyclase.
- Subjects
NITRIC oxide; CYCLIC guanylic acid; ADENOSINES; CARDIOVASCULAR agents
- Publication
British Journal of Pharmacology, 2002, Vol 135, Issue 2, p444
- ISSN
0007-1188
- Publication type
Article
- DOI
10.1038/sj.bjp.0704487